Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Epstein-Barr virus infection	4/202	7.083103438365334e-05	0.004636478878172474	26.4983164983165	-72.60755777125968	BCL2;BTK;MYC;MYD88
KEGG_2021_Human	Colorectal cancer	3/86	0.0001324740846980751	0.004636478878172474	41.230636833046475	-79.65388581050792	BCL2;MTOR;MYC
KEGG_2021_Human	Chemical carcinogenesis	4/239	0.00013636702582860217	0.004636478878172474	22.22127659574468	-61.560372574383265	BCL2;BCL6;MTOR;MYC
KEGG_2021_Human	NF-kappa B signaling pathway	3/104	0.0002329673917108638	0.005940668488627027	33.806223479490804	-67.40758155759835	BCL2;BTK;MYD88
KEGG_2021_Human	JAK-STAT signaling pathway	3/162	0.000856615716023289	0.012482114719196495	21.318059299191376	-44.62403509135876	BCL2;MTOR;MYC
KEGG_2021_Human	Hepatitis B	3/162	0.000856615716023289	0.012482114719196495	21.318059299191376	-44.62403509135876	BCL2;MYC;MYD88
KEGG_2021_Human	Gastric cancer	3/149	0.0006711090600743852	0.012482114719196495	23.25440313111546	-48.37496566440217	BCL2;MTOR;MYC
KEGG_2021_Human	Human immunodeficiency virus 1 infection	3/212	0.0018659404176712966	0.02379074032530903	16.115516062884485	-34.04865723073064	BCL2;MTOR;MYD88
KEGG_2021_Human	Salmonella infection	3/249	0.0029568377027043165	0.027071304477213724	13.627177700348431	-28.69609856443984	BCL2;MYC;MYD88
KEGG_2021_Human	Central carbon metabolism in cancer	2/70	0.0031848593502604382	0.027071304477213724	29.41176470588235	-37.553176952571945	MTOR;MYC
KEGG_2021_Human	Shigellosis	3/246	0.002856466854245349	0.027071304477213724	13.800705467372135	-29.076248648200146	BCL2;MTOR;MYD88
KEGG_2021_Human	Acute myeloid leukemia	2/67	0.002921615714870147	0.027071304477213724	30.78076923076923	-39.02900444511024	MTOR;MYC
KEGG_2021_Human	Small cell lung cancer	2/92	0.005440715912052039	0.032961932974146305	22.16111111111111	-29.32328202848766	BCL2;MYC
KEGG_2021_Human	ErbB signaling pathway	2/85	0.004661598778005346	0.032961932974146305	24.051204819277107	-31.541623523071053	MTOR;MYC
KEGG_2021_Human	B cell receptor signaling pathway	2/81	0.004241897027183041	0.032961932974146305	25.281645569620252	-32.95657984925952	BTK;CD79B
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.005099890907028776	0.032961932974146305	22.933908045977013	-30.23706529396038	MTOR;MYD88
KEGG_2021_Human	MicroRNAs in cancer	3/310	0.00549365549569105	0.032961932974146305	10.83434155421126	-22.425343286065555	BCL2;MTOR;MYC
KEGG_2021_Human	Prostate cancer	2/97	0.006031622120792857	0.03417919201782619	20.981578947368423	-27.909669646620806	BCL2;MTOR
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.03872627324202784	9.422466422466423	-19.140881053489387	BCL2;MTOR;MYC
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.007564767477927373	0.03872627324202784	18.600467289719628	-24.98176436194636	BCL2;MTOR
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.03872627324202784	18.086363636363636	-24.33571316400054	BCL2;MYD88
KEGG_2021_Human	Thyroid hormone signaling pathway	2/121	0.009256905435456077	0.042918379746205444	16.699579831932773	-22.566638560549244	MTOR;MYC
KEGG_2021_Human	Autophagy	2/137	0.011753397776716717	0.04930416062218295	14.690740740740742	-19.931093924152265	BCL2;MTOR
KEGG_2021_Human	Measles	2/139	0.012084353093672291	0.04930416062218295	14.472627737226277	-19.639406588988233	BCL2;MYD88
KEGG_2021_Human	Estrogen signaling pathway	2/137	0.011753397776716717	0.04930416062218295	14.690740740740742	-19.931093924152265	BCL2;KRT20
KEGG_2021_Human	Breast cancer	2/147	0.013449368234662449	0.05276290615136807	13.660344827586206	-18.543070369415922	MTOR;MYC
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.05690353090737581	12.847402597402597	-17.429441058365175	MTOR;MYC
KEGG_2021_Human	Hepatocellular carcinoma	2/168	0.01733904421063664	0.06316366105303348	11.900602409638553	-16.11078229535683	MTOR;MYC
KEGG_2021_Human	NOD-like receptor signaling pathway	2/181	0.019962543247368986	0.06638176630129035	11.018156424581006	-14.859767863470836	BCL2;MYD88
KEGG_2021_Human	Tuberculosis	2/180	0.019755026308062106	0.06638176630129035	11.081460674157304	-14.950240051620256	BCL2;MYD88
KEGG_2021_Human	Herpes simplex virus 1 infection	3/498	0.020174850542549024	0.06638176630129035	6.556709956709956	-12.239051897711217	BCL2;MTOR;MYD88
KEGG_2021_Human	Transcriptional misregulation in cancer	2/192	0.0223068963273402	0.06962448895103562	10.365789473684211	-13.920708621090329	BCL6;MYC
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.06962448895103562	10.31020942408377	-13.840129933766221	MTOR;MYC
KEGG_2021_Human	Pathways in cancer	3/531	0.02393281759639253	0.0717984527891776	6.12012987012987	-11.164029011261546	BCL2;MTOR;MYC
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.025220492252545426	0.07349972027884667	9.685960591133005	-12.928804077098514	MTOR;MYC
KEGG_2021_Human	Lipid and atherosclerosis	2/215	0.027564399546120597	0.07809913204734169	9.219483568075118	-12.240131856521	BCL2;MYD88
KEGG_2021_Human	Human cytomegalovirus infection	2/225	0.029995320515188703	0.08268980250133103	8.794843049327355	-11.607417281005194	MTOR;MYC
KEGG_2021_Human	African trypanosomiasis	1/37	0.04489527895199197	0.11741842187444054	24.790123456790123	-13.876145105511855	MYD88
KEGG_2021_Human	Thyroid cancer	1/37	0.04489527895199197	0.11741842187444054	24.790123456790123	-13.876145105511855	MYC
KEGG_2021_Human	Primary immunodeficiency	1/38	0.046083072411820386	0.11751183465014199	24.117117117117118	-13.560364723090352	BTK
KEGG_2021_Human	Bladder cancer	1/41	0.04963848036556211	0.12055059517350798	22.3	-12.692261742471414	MYC
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.12055059517350798	6.657534246575342	-8.337786615237395	MYC;MYD88
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.131740507171452	19.809876543209878	-11.46289716991079	MTOR
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.13963165098416802	18.183673469387756	-10.63265628196324	MYD88
KEGG_2021_Human	Hedgehog signaling pathway	1/56	0.06723726744113623	0.1509631998482624	16.187878787878788	-9.580691348846925	BCL2
KEGG_2021_Human	Legionellosis	1/57	0.06840002327828267	0.1509631998482624	15.896825396825397	-9.424000900813787	MYD88
KEGG_2021_Human	Endometrial cancer	1/58	0.06956147443988561	0.1509631998482624	15.61598440545809	-9.271975415581295	MYC
KEGG_2021_Human	Amyotrophic lateral sclerosis	2/364	0.07172754804182349	0.15242103958887493	5.321823204419889	-6.226988268408014	BCL2;MTOR
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.16644739269943726	13.26865671641791	-7.96724592924887	BTK
KEGG_2021_Human	Pancreatic cancer	1/76	0.09024597396088518	0.16644739269943726	11.841481481481482	-7.141387005986298	MTOR
KEGG_2021_Human	Chronic myeloid leukemia	1/76	0.09024597396088518	0.16644739269943726	11.841481481481482	-7.141387005986298	MYC
KEGG_2021_Human	Glioma	1/75	0.0891077855134448	0.16644739269943726	12.003003003003004	-7.236197160831004	MTOR
KEGG_2021_Human	Pertussis	1/76	0.09024597396088518	0.16644739269943726	11.841481481481482	-7.141387005986298	MYD88
KEGG_2021_Human	p53 signaling pathway	1/73	0.0868275630671275	0.16644739269943726	12.339506172839506	-7.43259286356604	BCL2
KEGG_2021_Human	Leishmaniasis	1/77	0.09138288226635771	0.16644739269943726	11.68421052631579	-7.04872976578505	MYD88
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.16644739269943726	13.071895424836601	-7.854937277937848	MTOR
KEGG_2021_Human	Choline metabolism in cancer	1/98	0.11496450084552494	0.19181941465078953	9.130584192439862	-5.49346810373269	MTOR
KEGG_2021_Human	Chagas disease	1/102	0.11939326812281527	0.19181941465078953	8.764576457645765	-5.262086311101535	MYD88
KEGG_2021_Human	Longevity regulating pathway	1/102	0.11939326812281527	0.19181941465078953	8.764576457645765	-5.262086311101535	MTOR
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.11718138394436346	0.19181941465078953	8.94388327721661	-5.375723879218761	BCL2
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.19181941465078953	9.528076463560334	-5.7422174156532195	MYC
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.19181941465078953	8.2668743509865	-4.943743954376122	MTOR
KEGG_2021_Human	Toll-like receptor signaling pathway	1/104	0.12160016340314761	0.19181941465078953	8.592233009708737	-5.152341092635986	MYD88
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.19181941465078953	8.345911949685535	-4.994589105830365	MTOR
KEGG_2021_Human	Pathways of neurodegeneration	2/475	0.11356791602477233	0.19181941465078953	4.014270613107822	-4.131104230952899	BCL2;MTOR
KEGG_2021_Human	Parathyroid hormone synthesis, secretion and action	1/106	0.12380207979004104	0.19181941465078953	8.426455026455027	-5.046288872333345	BCL2
KEGG_2021_Human	Staphylococcus aureus infection	1/95	0.11162978125448282	0.19181941465078953	9.425531914893616	-5.678293992521663	KRT20
KEGG_2021_Human	Neurotrophin signaling pathway	1/119	0.13799386385009413	0.197025639775252	7.4858757062146895	-4.435243302362896	BCL2
KEGG_2021_Human	Growth hormone synthesis, secretion and action	1/119	0.13799386385009413	0.197025639775252	7.4858757062146895	-4.435243302362896	MTOR
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.197025639775252	7.4858757062146895	-4.435243302362896	BCL2
KEGG_2021_Human	AMPK signaling pathway	1/120	0.13907692219429554	0.197025639775252	7.4220354808590105	-4.393179099544486	MTOR
KEGG_2021_Human	Cholinergic synapse	1/113	0.1314697223892576	0.197025639775252	7.892857142857143	-4.701617375992292	BCL2
KEGG_2021_Human	Platelet activation	1/124	0.14339691916847833	0.19765521290790256	7.177055103884372	-4.231046804704064	BTK
KEGG_2021_Human	Cell cycle	1/124	0.14339691916847833	0.19765521290790256	7.177055103884372	-4.231046804704064	MYC
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1466241030974613	0.19940878021254735	7.00352733686067	-4.115510268264927	BTK
KEGG_2021_Human	Insulin signaling pathway	1/137	0.15730251033809037	0.20111411364931295	6.480392156862745	-3.763669230249352	MTOR
KEGG_2021_Human	Apelin signaling pathway	1/137	0.15730251033809037	0.20111411364931295	6.480392156862745	-3.763669230249352	MTOR
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.20111411364931295	6.7846153846153845	-3.968927686510734	BCL6
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.20111411364931295	6.384863123993559	-3.698840756963446	BCL2
KEGG_2021_Human	Spinocerebellar ataxia	1/143	0.163651680714637	0.20111411364931295	6.2018779342723	-3.57415842622014	MTOR
KEGG_2021_Human	Yersinia infection	1/137	0.15730251033809037	0.20111411364931295	6.480392156862745	-3.763669230249352	MYD88
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	1/143	0.163651680714637	0.20111411364931295	6.2018779342723	-3.57415842622014	MYC
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.20111411364931295	6.2466509062253746	-3.6047270952512624	BCL2
KEGG_2021_Human	Phospholipase D signaling pathway	1/148	0.16890973234869874	0.2051046749948485	5.987150415721844	-3.427000500776257	MTOR
KEGG_2021_Human	Adrenergic signaling in cardiomyocytes	1/150	0.1710046090025842	0.20520553080310105	5.905294556301268	-3.370661515310376	BCL2
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.20777175975192913	5.74800290486565	-3.2620286219941206	MTOR
KEGG_2021_Human	Hepatitis C	1/157	0.17829930575122027	0.20904056536349963	5.635327635327635	-3.183908163692195	MYC
KEGG_2021_Human	Necroptosis	1/159	0.18037286671285227	0.2090685500535333	5.562587904360056	-3.1333425612983894	BCL2
KEGG_2021_Human	Hippo signaling pathway	1/163	0.1845058664849509	0.2114561615894943	5.422496570644719	-3.0356632226338247	MYC
KEGG_2021_Human	Wnt signaling pathway	1/166	0.1875932968535885	0.21260573643406697	5.321885521885521	-2.9652743858654524	MYC
KEGG_2021_Human	Influenza A	1/172	0.1937366175133076	0.2147949455038845	5.131254061078622	-2.8313674486945275	MYD88
KEGG_2021_Human	Protein processing in endoplasmic reticulum	1/171	0.19271564324144907	0.2147949455038845	5.162091503267974	-2.8530763101358976	BCL2
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.23132756812470803	4.657210401891253	-2.4954112144854435	MTOR
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.21888628489075546	0.23751490488145807	4.462585034013605	-2.3563138595912863	MYD88
KEGG_2021_Human	Focal adhesion	1/201	0.22284403856827387	0.2388671481559891	4.371111111111111	-2.2907190203417165	BCL2
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.2388671481559891	4.326732673267327	-2.2588473265567357	MTOR
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.25282490783892103	4.001019367991845	-2.0240281738454993	MYC
KEGG_2021_Human	Thermogenesis	1/232	0.25290994493508406	0.26057388266038967	3.7696007696007694	-1.8563524399324505	MTOR
KEGG_2021_Human	Coronavirus disease	1/232	0.25290994493508406	0.26057388266038967	3.7696007696007694	-1.8563524399324505	MYD88
KEGG_2021_Human	Huntington disease	1/306	0.32049274018188956	0.3269025949855274	2.8280510018214935	-1.1715156192121785	MTOR
KEGG_2021_Human	Human papillomavirus infection	1/331	0.3420488957114324	0.34543551844124853	2.6053872053872054	-1.0106876845884132	MTOR
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.3736370340305108	2.32487922705314	-0.8103995559567543	MTOR
